Related Experiment Video
Updated: May 20, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases
Basma Hossam Abdelmonem1,2, Lereen T Kamal1, Lilian Waheed Wardy3,4
1Institute of Global Health and Human Ecology, School of Sciences and Engineering, The American University in Cairo, New Cairo, Egypt.
Abstract:
Non-coding RNAs (ncRNAs) have a significant role in gene regulation, especially in cancer and inflammatory diseases. ncRNAs, such as microRNA, long non-coding RNAs, and circular RNAs, alter the transcriptional, post-transcriptional, and epigenetic gene expression levels. These molecules act as biomarkers and possible therapeutic targets because aberrant ncRNA expression has been directly connected to tumor progression, metastasis, and response to therapy in cancer research. ncRNAs' interactions with multiple cellular pathways, including MAPK, Wnt, and PI3K/AKT/mTOR, impact cellular processes like proliferation, apoptosis, and immune responses. The potential of RNA-based therapeutics, such as anti-microRNA and microRNA mimics, to restore normal gene expression is being actively studied. Additionally, the tissue-specific expression patterns of ncRNAs offer unique opportunities for targeted therapy. Specificity, stability, and immune responses are obstacles to the therapeutic use of ncRNAs; however, novel strategies, such as modified oligonucleotides and targeted delivery systems, are being developed. ncRNA profiling may result in more individualized and successful treatments as precision medicine advances, improving patient outcomes and creating early diagnosis and monitoring opportunities. The current review aims to investigate the roles of ncRNAs as potential biomarkers and therapeutic targets in cancer and inflammatory diseases, focusing on their mechanisms in gene regulation and their implications for non-invasive diagnostics and targeted therapies. A comprehensive literature review was conducted using PubMed and Google Scholar, focusing on research published between 2014 and 2025. Studies were selected based on rigorous inclusion criteria, including peer-reviewed status and relevance to ncRNA roles in cancer and inflammatory diseases. Non-English, non-peer-reviewed, and inconclusive studies were excluded. This approach ensures that the findings presented are based on high-quality and relevant sources.
Insights
Non-coding RNAs (ncRNAs) are key regulators in gene expression, impacting cancer and inflammatory diseases. Research highlights their potential as biomarkers and therapeutic targets for personalized medicine and diagnostics.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Non-coding RNAs (ncRNAs) regulate gene expression at transcriptional, post-transcriptional, and epigenetic levels.
- Aberrant ncRNA expression is linked to cancer progression, metastasis, and therapeutic response.
- ncRNAs interact with critical cellular pathways (MAPK, Wnt, PI3K/AKT/mTOR) influencing proliferation, apoptosis, and immune responses.
Purpose of the Study:
- To review the roles of ncRNAs as biomarkers and therapeutic targets in cancer and inflammatory diseases.
- To explore ncRNA mechanisms in gene regulation and their diagnostic/therapeutic implications.
- To assess the potential of ncRNA-based diagnostics and targeted therapies.
Main Methods:
- Comprehensive literature review of PubMed and Google Scholar (2014-2025).
- Inclusion of peer-reviewed studies on ncRNA roles in cancer and inflammatory diseases.
- Exclusion of non-English, non-peer-reviewed, and inconclusive studies.
Main Results:
- ncRNAs (microRNAs, long non-coding RNAs, circular RNAs) are crucial for gene regulation.
- ncRNA expression patterns offer potential for non-invasive diagnostics and targeted therapies.
- RNA-based therapeutics (anti-miRNAs, miRNA mimics) show promise, with ongoing development to address stability and delivery challenges.
Conclusions:
- ncRNAs represent significant biomarkers and therapeutic targets for cancer and inflammatory diseases.
- Precision medicine advancements leverage ncRNA profiling for individualized treatments and improved patient outcomes.
- Further research into ncRNA delivery and stability is crucial for clinical translation.
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Non-Canonical Wnt Signaling Pathways
Experimental RNAi

